Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/9760
Title: The tumor-specific de2-7 epidermal growth factor receptor (EGFR) promotes cells survival and heterodimerizes with the wild-type EGFR.
Austin Authors: Luwor, Rodney B;Zhu, Hong-Jian;Walker, Francesca;Vitali, Angela A;Perera, Rushika M;Burgess, Antony W;Scott, Andrew M ;Johns, Terrance G
Affiliation: Tumour Targeting Program, Ludwig Institute for Cancer Research, Melbourne Branch, Austin Hospital, Heidelberg 3084, Australia
Issue Date: 12-Aug-2004
Publication information: Oncogene; 23(36): 6095-104
Abstract: Mutations of the epidermal growth factor receptor (EGFR) gene are found at a relatively high frequency in glioma, with the most common being the de2-7 EGFR (or EGFRvIII). This mutation arises from an in-frame deletion of exons 2-7, which removes 267 amino acids from the extracellular domain of the receptor. Despite being unable to bind ligand, the de2-7 EGFR is constitutively active and imparts a significant in vivo growth advantage to glioma cells. In order to examine the signalling pathways activated by the de2-7 EGFR and its biological effects in an in vitro system, the de2-7 EGFR gene was transfected into the murine IL-3-dependent pro-B-cell line BaF/3. Expression of the de2-7 EGFR enhanced the survival of BaF/3 cells in the absence of IL-3 by reducing apoptosis in a phosphatidylinositol 3-kinase (PI3-K)-dependent manner. Interestingly, while de2-7 EGFR also enhanced proliferation of BaF/3 cells in low levels of IL-3, this effect was independent of PI3-K. Survival and proliferation were further enhanced when BaF/3 cells were cotransfected with the de2-7 and wt EGFR. This was due to heterodimerization between the de2-7 and wt EGFR leading to trans-phosphorylation of the wt EGFR. This observation is directly relevant to glioma where de2-7 and wt EGFR appear to be coexpressed. Thus, expression of de2-7 EGFR in BaF/3 cells provides an in vitro model for evaluating the signalling pathways activated by this receptor.
Gov't Doc #: 15221011
URI: https://ahro.austin.org.au/austinjspui/handle/1/9760
DOI: 10.1038/sj.onc.1207870
Journal: Oncogene
URL: https://pubmed.ncbi.nlm.nih.gov/15221011
Type: Journal Article
Subjects: Animals
Cell Cycle
Cell Division
Cell Line
Cell Survival
Dimerization
Genes, erbB
Interleukin-3.pharmacology
Mice
Neoplasms.genetics
Receptor, Epidermal Growth Factor.genetics.metabolism
Sequence Deletion
Signal Transduction
Appears in Collections:Journal articles

Show full item record

Page view(s)

20
checked on Nov 19, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.